Pradžia › Berkito limfoma › Rhode Island › Providence

Berkito limfoma klinikiniai tyrimai Providence, RI

7 tyrimai dėl Berkito limfoma ieško dalyvių vietose Providence ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė

Rhode Island Hospital, Providence

366 Days – 46 Years · Visoms lytims · Atnaujinta 2026-10-02 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Renkami dalyviai3 fazė

Rhode Island Hospital, Providence

Amžius nuo 18 iki 39 · Visoms lytims · Atnaujinta 2026-10-02 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Renkami dalyviai2 fazė

Rhode Island Hospital, Providence

365 Days · Visoms lytims · Atnaujinta 2026-09-25 · NCT06317662

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai1 fazė

Lifespan Cancer Institute at Rhode Island Hospital, Providence

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė

Rhode Island Hospital, Providence

Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-09-01 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Renkami dalyviai3 fazė

Rhode Island Hospital, Providence

365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Renkami dalyviai1 fazė

Rhode Island Hospital, Providence

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT05544019

Berkito limfoma tyrimai kituose miestuose

Kiti tyrimai Providence

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.